US Broker Ratings

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 162% Potential Upside with Strategic Beauty Innovations

Evolus, Inc. (NASDAQ: EOLS) is garnering significant attention in the investment community due to its promising potential upside of 162.30%. As a performance beauty company, Evolus..

Immatics N.V. (IMTX) Stock Analysis: Exploring a Strong Buy Consensus Amidst a Potential 59% Upside

Immatics N.V. (NASDAQ: IMTX), a Germany-based clinical-stage biopharmaceutical company, is capturing investor attention with its promising foray into T cell redirecting immunotherapies aimed at combating cancer...

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Frontier with Resilient Potential

CureVac N.V. (NASDAQ: CVAC) emerges as a compelling player on the forefront of biotechnology, leveraging its expertise in messenger ribonucleic acid (mRNA) to pioneer transformative medical..

uniQure N.V. (QURE) Investor Outlook: Biotechnology Innovator with a 157% Upside Potential

For those with a keen eye on the healthcare sector, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity within the biotechnology industry. With its current stock..

Pharvaris N.V. (PHVS) Stock Analysis: Potential 68.99% Upside Beckons Investors

Investors in the biotechnology sector might want to turn their attention to Pharvaris N.V. (NASDAQ: PHVS), a promising player in the healthcare industry with a focus..

AMN Healthcare Services Inc (AMN): Investor Outlook with a Potential 11.62% Upside in the Healthcare Sector

AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, has garnered attention with its comprehensive suite of workforce solutions and staffing services tailored..

Niagen Bioscience, Inc. (NAGE): Stock Analysis Reveals 143% Potential Upside Amid Robust Revenue Growth

Niagen Bioscience, Inc. (NAGE), a burgeoning player within the biotechnology sector, is catching the eye of investors with its impressive revenue growth and promising market potential...

Ardelyx, Inc. (ARDX) Investor Outlook: A Potential 102.74% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company headquartered in Waltham, Massachusetts, is capturing attention with its promising potential upside of 102.74%. Operating in the healthcare sector,..

GH Research PLC (GHRS) Stock Analysis: Exploring a Potential 131.87% Upside in the Biotech Sector

GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology sector, has captured investor attention with its ambitious focus on developing groundbreaking treatments for depression...

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Biotechnology Innovator with a 113.97% Potential Upside

Nurix Therapeutics, Inc. (NRIX) is capturing the attention of investors, especially with analysts predicting a potential upside of 113.97%. As a clinical-stage biopharmaceutical company, Nurix is..

InMode Ltd. (INMD) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 15% Potential Upside

InMode Ltd. (NASDAQ: INMD), a key player in the healthcare sector, is carving a niche in the medical devices industry with its innovative aesthetic solutions. Based..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Unpacking Growth Potential Amidst Analyst Consensus

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a compelling player in the healthcare sector, specifically within the drug manufacturing industry, with a focus on specialty and generic..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Unveiling a 136% Potential Upside in the Biotech Sector

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology company, is capturing attention with its ambitious development pipeline in the treatment of inflammatory bowel disease (IBD). With a..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A Promising 9.69% Upside in the Pain Management Sector

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity for investors seeking growth in the healthcare sector, particularly within the specialized domain of pain management. With..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 98% Potential Upside in the Healthcare Sector

Nutex Health Inc. (NUTX), a prominent player in the healthcare sector, has captured investor attention with its ambitious expansion strategies and robust financial performance. As a..

CareDx, Inc. (CDNA) Stock Analysis: Evaluating a 45% Potential Upside in the Diagnostics Sector

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured the attention of investors with a compelling 45.46%..

Ringcentral, Inc. (RNG) Stock Analysis: Exploring a Solid 20% Potential Upside

Ringcentral, Inc. (NYSE: RNG), a stalwart in the cloud business communications sector, presents an intriguing prospect for investors as it navigates a competitive landscape marked by..

SAP SE (SAP) Stock Report: Potential Upside of 30.17% Attracts Investor Attention

SAP SE (SAP), the German-based enterprise software giant, continues to be a compelling presence in the technology sector, particularly in the software – application industry. With..

Alkami Technology, Inc. (ALKT) Stock Analysis: Exploring a 70% Potential Upside for Investors

Alkami Technology, Inc. (NASDAQ: ALKT) stands out in the technology sector with a compelling growth narrative centered around its innovative digital banking solutions. Based in Plano,..

DoubleVerify Holdings, Inc. (DV) Stock Analysis: Exploring a 65.92% Potential Upside

DoubleVerify Holdings, Inc. (NASDAQ: DV), a prominent player in the Technology sector, is making waves in the Software – Application industry. Headquartered in New York, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds